TP53 and endometrial cancer: Genes associated with lysosomal biogenesis, including LAMP3, LAMP1, RIN3, and NPC2, are PAX8 targets, and regulating PAX8-DDX5 interactions promotes c-MYC-associated cell cycle progression in endometrial cancer in patients with the TP53 mutation (87).